Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

07 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251006770906/en/BlueRock-Therapeutics-reports-positive-36-month-results-from-Phase-I-trial-of-bemdaneprocel-for-treating-Parkinsons-disease

26 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/bayer-owned-bluerock-lays-50-employees-shuts-cambridge-research-labs

02 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/sponsored/forging-future-cell-therapy-bayer-and-bluerocks-unique-journey

27 Sep 2024
// BUSINESSWIRE

31 May 2024
// INDINPHARMAPOST
https://www.indianpharmapost.com/drug-approval/bluerock-therapeutics-receives-fda-rmat-designation-for-parkinsons-disease-cell-therapy-candidate-bemdaneprocel-15706

06 Mar 2024
// PRESS RELEASE
https://www.bayer.com/media/en-us/bluerock-therapeutics-phase-i-clinical-trial-for-parkinsons-disease-continues-to-show-positive-trends-at-18-months/
ABOUT THIS PAGE